vaginal progesterone effective in intramuscular progesterone for embryo transfer

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2022-04-16 04:15 GMT | Update On 2022-04-16 10:07 GMT

Miscarriage is a leading cause infertility among women, progesterone a female hormone. This medicine is used to treat infertility and to prevent miscarriage in women with a condition called corpus luteum insufficiency. Recent studies suggests that progesterone in oil (PIO) is superior to vaginal progesterone (VP; Prometrium) for endometrial preparation in frozen embryo transfer cycles (FET), improving the live birth rate and reducing the rate of miscarriage. PIO has disadvantages including cost, pain, and stress of administration.

A recent study in Journal of Obstetrics and Gynaecology Canada says that In their single-centre experience, vaginal progesterone was non-inferior to progesterone in oil for endometrial preparation in frozen embryo transfer cycles.

A retrospective analysis comparing pregnancy, miscarriage, and live birth rates for PIO versus VP for medicated FET cycles, from 2017 to 2020 at a single fertility clinic. A total of 745 participants were included in the study; 438 received VP, and 307 received PIO. Univariate and multivariate binary and ordinal logistic regression analyses were performed to compare the rates of pregnancy, miscarriage, and live birth between VP and PIO.

The results demonstrated no difference between PIO and VP with respect to the rates of pregnancy (51% vs. 53%), miscarriage (20% vs. 18%), or live birth (31% vs. 34%) (all P > 0.05).

The researchers concluded that In a single-centre experience, VP was non-inferior to PIO for endometrial preparation in FET cycles.

Full View

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr Priyanka Ahuja

MBBS- MAMC Delhi, MS(Obstetrics & Gynaecology) - MUHS, Senior Residency- Safdarjung Hospital . Won numerous awards in the same field. Her interest lies in the field of Obstetrics, women and child health. At Medical Dialogues she talks about latest research in the field of Obstetrics, Gynaecology and Women Health. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

vaginal progesterone effective in intramuscular progesterone for embryo transfer

Similar News

GLP-1 Drugs Used for Weight Loss May Be Linked to Unplanned Pregnancies in Young Women: Study Finds

Study Explores Chip Using Vibration Technology to Simplify Fertility Treatments

Is Tylenol Safe in Pregnancy? New Study Highlights Potential Risks

WHO Leads Global Call to Include Pregnant, Lactating Women in TB Research

Study Sheds Light on Health Risks Involved with Early Puberty and Childbirth in Women

Heavy Drinking Linked to Higher Risk of Unintended Pregnancy: Study Finds

Pregnancy Complications Like Stillbirth and Preeclampsia May Predict Stroke Risk Before 50: Study Finds

Low Blood Sugar Before Pregnancy May Raise Risk of Preterm Birth, Low Birth Weight: Study Finds